Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients

Thrombosis in COVID-19 worsens mortality. In our study, we sought to investigate how the dose and type of anticoagulation (AC) can influence patient outcomes. This is a single-center retrospective analysis of critically ill intubated patients with COVID-19, comparing low-molecular-weight heparin (LM...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of vascular surgery. Venous and lymphatic disorders (New York, NY) NY), 2022-09, Vol.10 (5), p.1128-1136
Hauptverfasser:	Volteas, Panagiotis, Drakos, Panagiotis, Alkadaa, Leor N., Cleri, Nathaniel A., Asencio, Anthony A., Oganov, Anthony, Giannopoulos, Stefanos, Saadon, Jordan R., Mikell, Charles B., Rubano, Jerry A., Labropoulos, Nicos, Tassiopoulos, Apostolos K., Mofakham, Sima, Bannazadeh, Mohsen
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulation (AC) Clinical Research Study COVID-19 Low-molecular-weight heparin (LMWH) SARS-CoV-2 Thromboprophylaxis Unfractionated heparin (UFH)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!